EpimAb Biotherapeutics Raises $25M In Series A Financing From International Consortium To Advance Pipeline Of Novel Bispecific Antibodies Post author:Sam Post published:April 24, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Deal Spree Continues as Allergan Inks $2.47 Billion Deal for This Bay Area Biotech February 12, 2017 SYGNIS Reports Financial Results For The Second Quarter And First Six Months Of 2017 August 2, 2017 New FDA Head Lifts Hiring Freeze, Takes Aim at the Next and Marathon Pharma May 25, 2017